Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20048212.
- Also identified by DOI 10.1161/CIRCULATIONAHA.109.192665.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite improvements in cardiovascular implantable electronic device (CIED) design, application of timely infection control practices, and administration of antibiotic prophylaxis at the time of device placement, CIED infections continue to occur and can be life-threatening. This has prompted the study of all aspects of CIED infections. Recognizing the recent advances in our understanding of the epidemiology, risk factors, microbiology, management, and prevention of CIED infections, the American Heart Association commissioned this scientific statement to educate clinicians about CIED infections, provide explicit recommendations for the care of patients with suspected or established CIED infections, and highlight areas of needed research.
Medical subject headings
- Cardiology
- Defibrillators, Implantable
- Pacemaker, Artificial
- Prosthesis-Related Infections